エピソード

  • Episode 2: From Innovation to Impact: The RNA Interference Era Begins

    Episode 2: From Innovation to Impact: The RNA Interference Era Begins
    2025/06/11

    Dr. Bruce Given shares insights into Arrowhead Pharmaceuticals’ innovative approach to siRNA therapeutics and the company’s growing role in lipid management and cardiovascular care. Hosted by Dr. Peter Jones, this conversation highlights the intersection of clinical need and next-gen molecular science.

    続きを読む 一部表示
    39 分